Author Login IJIRT Partner Network (IPN) Login

Phenotypic Screening in Drug Discovery

  • Unique Paper ID: 161327
  • Volume: 10
  • Issue: 3
  • PageNo: 307-311
  • Abstract:
  • In most cases, phenotypic screening has resulted in the invention of novel drugs. Compounds are distinct cell or creature sickness models used to identify intensities that induce a beneficial alteration in aggregate. Only after the mixtures have been invent are efforts undertaken to detect the mixtures' natural focuses - a cycle known as target deconvolution. More recently, it has been well known to cultivate a hypothesis that a specific organic objective is infection changing, and after that screen for intensifies that modify the action of this cleansed target. Following that, these mixes their testing was carried out on animals whether changes are occurred. This method is referred to as "switch pharmacology" or "target based drug revelation". Late quantifiable evaluation, however, reveals that phenotypic screening produces a disproportionate number of first-in-class medications with unique systems of activity, prompting a resurgence of interest in this technique.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 10
  • Issue: 3
  • PageNo: 307-311

Phenotypic Screening in Drug Discovery

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry